Drug Trial Radar · NCT05232929
Long-term Follow-up Study of Risdiplam in Participants With Spinal Muscular Atrophy (SMA)
Last checked: Nov 19, 2026Latest source record: Oct 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
403
Actual
Start
Mar 29, 2022
Primary completion
Oct 9, 2026
Study completion Oct 9, 2026
Sponsor
- Lead sponsor
- Genentech, Inc.Roche (Genentech) (RHHBY)
- Sponsor type
- Industry
- First posted
- Feb 10, 2022
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A multi-center, longitudinal, prospective, non-comparative study to investigate the long-term safety and effectiveness of risdiplam, prescribed based on clinician judgment as per the Evrysdi® U.S. Package Information (USPI) in adult and pediatric participants with SMA. In this study, participants will be followed for approximately 24 months from enrollment or until withdrawal of consent, loss to follow-up, or death. Participants who discontinue risdiplam may still remain in the study if they agree to continue participating in the follow-up assessments. An optional sub-study was planned to assess the feasibility, acceptability, and adherence of remote assessment of motor and bulbar functions in participants with SMA using wearable and smartphone-based biosensors. This substudy was withdrawn upon implementation of protocol version 4.
Conditions
- Spinal Muscular Atrophy
Interventions
RisdiplamDrug
Risdiplam taken by participants as prescribed by their physician.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Adverse Events (AEs), Adverse Events of Special Interest (AESIs), and Serious Adverse Events (SAEs)Time frame: From enrollment up to the duration of the study or until withdrawal of consent, loss to follow-up, or death (up to approximately 24 months)
Locations
38 sites in 2 countries. Site status is shown where the registry gives one.
Barrow Neurological Institute
Phoenix, Arizona
Phoenix Children's Hospital
Phoenix, Arizona
University of Arkansas for Medical Sciences
Little Rock, Arkansas
Loma Linda University Health Care
Loma Linda, California
Children's Hospital Los Angeles
Los Angeles, California
Valley Children's Hospital
Madera, California
University California - Irvine
Orange, California
University of California Davis Medical Center
Sacramento, California
University of Colorado
Aurora, Colorado
Medstar Georgetown University Hospital
Washington D.C., District of Columbia
Children's National Hospital
Washington D.C., District of Columbia
Nemour's Children's Hospital, Florida
Orlando, Florida
All Children's Research Institute, Inc.
St. Petersburg, Florida
Advent Health Orlando
Winter Park, Florida
Rare Disease Research, LLC
Atlanta, Georgia
University of Kentucky Medical Center
Lexington, Kentucky
Norton Children's Hospital
Louisville, Kentucky
Massachusetts General Hospital
Boston, Massachusetts
University of Michigan Pediatric Rehabilitation Center
Ann Arbor, Michigan
Helen DeVos Children's Hospital at Spectrum Health
Grand Rapids, Michigan
Gillette Children's Specialty Healthcare
Minnetonka, Minnesota
Mayo Clinic
Rochester, Minnesota
Washington University;Wash Uni. Sch. Of Med
St Louis, Missouri
NYU Hospital for Joint Diseases
New York, New York
Columbia University Med Center
New York, New York
Cincinnati Childrens Hospital
Cincinnati, Ohio
Penn State Milton S. Hershey Medical Center
Hershey, Pennsylvania
Childrens Hospital of Philadelphia
Philadelphia, Pennsylvania
University of Texas at Austin Health sciences, Dell Medical School
Austin, Texas
Neurology & Neuromuscular Care Center
Denton, Texas
Central Texas Neurology Consultants
Round Rock, Texas
Methodist Children's Hospital of South Texas
San Antonio, Texas
University Of Utah
Salt Lake City, Utah
University of Virginia Children?s Hospital
Charlottesville, Virginia
MultiCare Health System Institute for Research and Innovation
Tacoma, Washington
UBC (Remote Coordinating Center, no physical facility)
Morgantown, West Virginia
Childrens Hospital of Wisconsin
Milwaukee, Wisconsin
Instituto de Rehabilitación del Caribe
Santurce, Puerto Rico
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.